Evidence map›Paper›PMID 37183778›Full record

ArticleMagnetic resonance in medicine2023

Vespa: Integrated applications for RF pulse design, spectral simulation and MRS data analysis.

Brian J Soher, Philip Semanchuk, David Todd, Xiao Ji, Dinesh Deelchand, James Joers, Gulin Oz, Karl Young

Abstract read
In one paragraph

Article in Magnetic resonance in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed.

  1. Trial
  2. N-Acetylcysteine rapidly replenishes central nervous system glutathione measured via magnetic resonance spectroscopy in human neonates with hypoxic-ischemic encephalopathy.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A Digital Phantom for MR Spectroscopy Data Simulation.Magnetic resonance in medicine · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Brian J SoherCenter for Advanced MR Development, Department of Radiology, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0003-2750-7277
Philip SemanchukCenter for Advanced MR Development, Department of Radiology, Duke University Medical Center, Durham, NC, USA.
David ToddCenter for Imaging of Neurodegenerative Disorders, University of California, San Francisco, CA, USA.
Xiao JiCenter for Advanced MR Development, Department of Radiology, Duke University Medical Center, Durham, NC, USA.
Dinesh DeelchandCenter for Magnetic Resonance Research, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, USA.ORCID 0000-0003-4266-4780
James JoersCenter for Magnetic Resonance Research, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, USA.ORCID 0000-0002-8444-2185
Gulin OzCenter for Magnetic Resonance Research, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, USA.ORCID 0000-0002-5769-183X
Karl YoungDepartment of Radiology, University of California, San Francisco, CA, USA.

Funding

PARTNERSHIP FOR MR SPECTROSCOPIC IMAGING DATA PROCESSINGR01EB000822 · NIBIB · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MAUDSLEY, ANDREW A. · 2002 to 2012
$10.8M
Partnership for Magnetic Resonance Spectroscopy Biomarker Development-SupplementR01NS080816 · NINDS · UNIVERSITY OF MINNESOTA · PI OZ, GULIN · 2015 to 2019
$3.2M
MrSPA: Integrated tools and development platform for magnetic resonance researchR01EB008387 · NIBIB · DUKE UNIVERSITY · PI SOHER, BRIAN J, YOUNG, KARL A · 2008 to 2010
$1.2M
NIBIB NIH HHS R01 EB000822NIBIB NIH HHS R01 EB008387NINDS NIH HHS R01 NS080816
6 · The paper itself

Abstract

purposeThe Vespa package (Versatile Simulation, Pulses, and Analysis) is described and demonstrated. It provides workflows for developing and optimizing linear combination modeling (LCM) fitting for THEORY AND

methodsVespa is written in Python for compatibility across operating systems. It embeds the PyGAMMA spectral simulation library for spectral simulation. Multiprocessing methods accelerate processing and visualization. Applications use the Vespa database for results storage and cross-application access. Three projects demonstrate pulse, sequence, simulation, and data analysis workflows: (1) short TE semi-LASER single-voxel spectroscopy (SVS) LCM fitting, (2) optimizing MEGA-PRESS (MEscher-GArwood Point RESolved Spectroscopy) flip angle and LCM fitting, and (3) creating a synthetic short TE dataset.

resultsThe LCM workflows for in vivo basis set creation and spectral analysis showed reasonable results for both the short TE semi-LASER and MEGA-PRESS. Examples of pulses, simulations, and data fitting are shown in Vespa application interfaces for various steps to demonstrate the interactive workflow.

conclusionVespa provides an efficient and extensible platform for characterizing RF pulses, pulse design, spectral simulation optimization, and automated LCM fitting via an interactive platform. Modular design and command line interface make it easy to embed in other platforms. As open source, it is free to the MRS community for use and extension. Vespa source code and documentation are available through GitHub.

Indexed as

SoftwareComputer SimulationDatabases, FactualHeart RateMagnetic Resonance SpectroscopyGAMMAlinear combination modelingmagnetic resonance spectroscopyMRSRF pulsespectral analysisspectral simulation

Identifiers

PMID37183778
PMCPMC10330446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.